Asston Pharmaceuticals Ltd — Important, 30-03-2026: Company Update

Asston Pharmaceuticals has announced key leadership changes. Mr. Sumit Pawar has been appointed as Chief Financial Officer, effective March 30. The company also welcomed Mr. Yashvardhan Tupe as an Additional Non-Executive Director and Mr. Sandip Sharma as an Additional Non-Executive Independent Director, also effective March 30. These strategic appointments aim to enhance the company's financial management, governance, and long-term business strategy. Furthermore, the company has announced an Extraordinary General Meeting (EGM) on April 28, 2026, to address upcoming shareholder matters.